In the group of CKD patients treated with β-blockers, a similar median value of MMP-2 [189.6 (142.8–234.6) ng/mL)] was observed compared to the controls [192.3 (176.5–214.1 ng/mL)]. This evidence concerns the gene MMP2 and chronic kidney disease.